Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB
IJTLD Open · 2026-02 · 3 (2) · 108-110
DOI: 10.5588/ijtldopen.25.0494 ↗Kurz gefasst
Leserbrief in der Zeitschrift IJTLD Open, online erschienen am 01.02.2026. Verfasst von T M P Nguyen und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Lung Hospital, Hanoi, Vietnam. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Lung Hospital, Hanoi, Vietnam.
- Department of Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium.
- Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
- The Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.
- Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy.
- Global Programme on Tuberculosis and Lung Health, World Health Organization, Geneva, Switzerland.
Förderung
- World Health Organization
Zitieren
APA
Nguyen, T. M. P., Le, T. H. M., Merle, C. S. C., Guglielmetti, L., Nguyen, N. L., Dinh, V. L., Nguyen, B. H., Hoang, T. T. T., Nguyen, V. N., Callens, S., & Decroo, T. (2026). Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB. IJTLD Open, 3(2), 108-110. https://doi.org/10.5588/ijtldopen.25.0494
Vancouver
Nguyen TMP, Le THM, Merle CSC, Guglielmetti L, Nguyen NL, Dinh VL, et al. Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB. IJTLD Open. 2026;3(2):108-110. doi:10.5588/ijtldopen.25.0494
BibTeX
@article{Nguyen2026,
author = {Nguyen, T M P and Le, T H M and Merle, C S C and Guglielmetti, L and Nguyen, N L and Dinh, V L and Nguyen, B H and Hoang, T T T and Nguyen, V N and Callens, S and Decroo, T},
title = {Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB},
journal = {IJTLD Open},
year = {2026},
volume = {3},
number = {2},
pages = {108--110},
doi = {10.5588/ijtldopen.25.0494}
}
EUVIMED